ArticleBlood advances2021
Comorbidities and malignancies negatively affect survival in myelodysplastic syndromes: a population-based study.
Johanne Rozema et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it